OmniAb (OABI) EBITDA Margin (2022 - 2026)
OmniAb (OABI) reported EBITDA Margin of 54.27% for Q1 2026, up 39937.0% year-over-year from N/an in Q1 2025, and up 71.17% quarter-over-quarter from 188.23% in Q4 2025.
OmniAb (OABI) EBITDA Margin (2022 - 2026) Analysis & Trends
OmniAb (OABI) has 5 years of EBITDA Margin data on file, last reported at 54.27% in Q1 2026.
- EBITDA Margin for Q1 2026 came in at 54.27%, up 39937.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 200.26% (up 6444.0% YoY), and the FY2025 annual result was 369.49%, down 8719.0% from the prior year.
- EBITDA Margin improved to 54.27% in Q1 2026 per OABI's latest filing, from 188.23% in the prior quarter.
- Over five years, EBITDA Margin peaked at 19.32% in Q4 2022 and troughed at 810.18% in Q3 2025.
- A 5-year average of 267.5% and a median of 212.84% in 2023 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2024 and 2026: EBITDA Margin slumped 55728 bps in 2024, then surged 39937 bps in 2026.
- A 5-year view of EBITDA Margin shows it stood at 19.32% in 2022, then slumped by 1598 bps to 289.38% in 2023, then jumped by 49 bps to 146.98% in 2024, then decreased by 28 bps to 188.23% in 2025, then jumped by 71 bps to 54.27% in 2026.
- Business Quant data shows OABI's EBITDA Margin at 54.27% in Q1 2026, 188.23% in Q4 2025, and 810.18% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | -54.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -54.27% |
| Dec 31, 2025 | -188.23% |
| Sep 30, 2025 | -810.18% |
| Jun 30, 2025 | -416.19% |
| Mar 31, 2025 | -453.64% |
| Dec 31, 2024 | -146.98% |
| Sep 30, 2024 | -473.73% |
| Jun 30, 2024 | -214.14% |
| Mar 31, 2024 | -593.34% |
| Dec 31, 2023 | -289.38% |
| Sep 30, 2023 | -287.35% |
| Jun 30, 2023 | -212.84% |
| Mar 31, 2023 | -36.07% |
| Dec 31, 2022 | 19.32% |
| Sep 30, 2022 | -182.29% |
| Jun 30, 2022 | -142.74% |
| Mar 31, 2022 | -65.44% |